iShares Biotechnology ETF (IBB)
Net flows (30d): +$29.7M Estimated from creation/redemption of shares outstanding
IBB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -3.98% | ▼ -3.98% |
| 3M | ▲ +4.90% | ▲ +4.91% |
| 6M | ▲ +21.17% | ▲ +21.19% |
| YTD | ▲ +21.64% | ▲ +21.75% |
| 1Y | ▲ +37.21% | ▲ +37.48% |
| 3Y | ▲ +70.17% | ▲ +71.39% |
| 5Y | ▲ +29.17% | ▲ +30.81% |
| Max | ▲ +495.04% | ▲ +521.57% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 249 holdings
| Issuer | Ticker | Weight % | Market value | Shares | CUSIP | Units/share | Type | Currency |
|---|---|---|---|---|---|---|---|---|
| COGENT BIOSCIENCES | COGT | 0.37 | ≈$38.3M | 1,125,962 | 19240Q201 | 0.02216 | EQUITY | USD |
| MIRUM PHARMACEUTICALS | MIRM | 0.37 | ≈$38.1M | 379,636 | 604749101 | 0.007473 | EQUITY | USD |
| DEFINIUM THERAPEUTICS INC | DFTX | 0.36 | ≈$36.7M | 974,814 | 24477V105 | 0.01919 | EQUITY | USD |
| ACADIA PHARMACEUTICALS | ACAD | 0.35 | ≈$35.8M | 1,293,913 | 004225108 | 0.02547 | EQUITY | USD |
| CRISPR THERAPEUTICS AG | CRSP | 0.35 | ≈$35.7M | 685,566 | CH0334081137 | 0.0135 | EQUITY | USD |
| ORUKA THERAPEUTICS INC | ORKA | 0.34 | ≈$35.4M | 387,461 | 687604108 | 0.007627 | EQUITY | USD |
| CG ONCOLOGY | CGON | 0.31 | ≈$31.5M | 438,814 | 156944100 | 0.008638 | EQUITY | USD |
| ERASCA | ERAS | 0.29 | ≈$30.1M | 1,881,079 | 29479A108 | 0.03703 | EQUITY | USD |
| ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.28 | ≈$28.5M | 1,179,205 | 00650F109 | 0.02321 | EQUITY | USD |
| AMYLYX PHARMACEUTICALS | AMLX | 0.25 | ≈$25.9M | 810,880 | 03237H101 | 0.01596 | EQUITY | USD |
| EDGEWISE THERAPEUTICS | EWTX | 0.25 | ≈$25.6M | 599,006 | 28036F105 | 0.01179 | EQUITY | USD |
| TARSUS PHARMACEUTICALS | TARS | 0.24 | ≈$24.9M | 308,150 | 87650L103 | 0.006066 | EQUITY | USD |
| VERACYTE | VCYT | 0.24 | ≈$24.9M | 593,253 | 92337F107 | 0.01168 | EQUITY | USD |
| DENALI THERAPEUTICS | DNLI | 0.24 | ≈$24.2M | 1,135,594 | 24823R105 | 0.02235 | EQUITY | USD |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.23 | ≈$24.0M | 2,961,520 | 462260100 | 0.0583 | EQUITY | USD |
| ENLIVEN THERAPEUTICS | ELVN | 0.23 | ≈$23.7M | 423,426 | 29337E102 | 0.008335 | EQUITY | USD |
| IDEAYA BIOSCIENCES | IDYA | 0.23 | ≈$23.7M | 634,181 | 45166A102 | 0.01248 | EQUITY | USD |
| RELAY THERAPEUTICS | RLAY | 0.23 | ≈$23.6M | 1,251,124 | 75943R102 | 0.02463 | EQUITY | USD |
| IMMUNOVANT | IMVT | 0.23 | ≈$23.5M | 618,035 | 45258J102 | 0.01217 | EQUITY | USD |
| GRAIL INC | GRAL | 0.23 | ≈$23.4M | 302,532 | 384747101 | 0.005955 | EQUITY | USD |
| CARIS LIFE SCIENCES | CAI | 0.22 | ≈$22.4M | 935,069 | 142152107 | 0.01841 | EQUITY | USD |
| IMMUNITYBIO | IBRX | 0.21 | ≈$22.1M | 2,871,255 | 45256X103 | 0.05652 | EQUITY | USD |
| UNIQURE | QURE | 0.21 | ≈$21.8M | 492,076 | NL0010696654 | 0.009687 | EQUITY | USD |
| LEGEND BIOTECH ADR REP | LEGN | 0.21 | ≈$21.7M | 1,132,518 | 52490G102 | 0.02229 | EQUITY | USD |
| TANGO THERAPEUTICS | TNGX | 0.21 | ≈$21.2M | 910,926 | 87583X109 | 0.01793 | EQUITY | USD |
| DYNE THERAPEUTICS | DYN | 0.20 | ≈$21.0M | 1,142,515 | 26818M108 | 0.02249 | EQUITY | USD |
| ARCUTIS BIOTHERAPEUTICS | ARQT | 0.19 | ≈$19.7M | 842,985 | 03969K108 | 0.01659 | EQUITY | USD |
| NURIX THERAPEUTICS | NRIX | 0.19 | ≈$19.3M | 749,550 | 67080M103 | 0.01475 | EQUITY | USD |
| ABCELLERA BIOLOGICS | ABCL | 0.18 | ≈$18.7M | 1,792,165 | 00288U106 | 0.03528 | EQUITY | USD |
| CAREDX | CDNA | 0.17 | ≈$17.8M | 356,183 | 14167L103 | 0.007011 | EQUITY | USD |
| STRUCTURE THERAPEUTICS ADR | GPCR | 0.17 | ≈$17.6M | 446,155 | 86366E106 | 0.008783 | EQUITY | USD |
| SUMMIT THERAPEUTICS | SMMT | 0.17 | ≈$17.4M | 1,027,519 | 86627T108 | 0.02023 | EQUITY | USD |
| BEAM THERAPEUTICS | BEAM | 0.17 | ≈$17.4M | 715,740 | 07373V105 | 0.01409 | EQUITY | USD |
| ARCUS BIOSCIENCES | RCUS | 0.16 | ≈$16.7M | 639,708 | 03969F109 | 0.01259 | EQUITY | USD |
| ZAI LABORATORY ADR REPRESENTING LT | ZLAB | 0.16 | ≈$16.5M | 684,677 | 98887Q104 | 0.01348 | EQUITY | USD |
| ADMA BIOLOGICS | ADMA | 0.16 | ≈$16.2M | 1,726,703 | 000899104 | 0.03399 | EQUITY | USD |
| SAREPTA THERAPEUTICS | SRPT | 0.15 | ≈$15.8M | 772,730 | 803607100 | 0.01521 | EQUITY | USD |
| DISC MEDICINE | IRON | 0.15 | ≈$15.7M | 211,840 | 254604101 | 0.00417 | EQUITY | USD |
| VERA THERAPEUTICS CLASS A | VERA | 0.15 | ≈$15.0M | 447,454 | 92337R101 | 0.008808 | EQUITY | USD |
| VERICEL | VCEL | 0.14 | ≈$14.6M | 386,903 | 92346J108 | 0.007616 | EQUITY | USD |
| KODIAK SCIENCES | KOD | 0.14 | ≈$14.5M | 443,467 | 50015M109 | 0.00873 | EQUITY | USD |
| AGIOS PHARMACEUTICALS | AGIO | 0.14 | ≈$14.3M | 425,302 | 00847X104 | 0.008372 | EQUITY | USD |
| ZYMEWORKS | ZYME | 0.14 | ≈$14.2M | 537,742 | 98985Y108 | 0.01059 | EQUITY | USD |
| AURINIA PHARMACEUTICALS | AUPH | 0.14 | ≈$13.9M | 867,868 | 05156V102 | 0.01708 | EQUITY | USD |
| MBX BIOSCIENCES | MBX | 0.13 | ≈$13.7M | 225,121 | 55287L101 | 0.004432 | EQUITY | USD |
| BIOCRYST PHARMACEUTICALS | BCRX | 0.13 | ≈$13.7M | 1,651,139 | 09058V103 | 0.0325 | EQUITY | USD |
| MINERALYS THERAPEUTICS | MLYS | 0.13 | ≈$13.5M | 463,531 | 603170101 | 0.009125 | EQUITY | USD |
| NEWAMSTERDAM PHARMA | NAMS | 0.13 | ≈$13.4M | 612,706 | NL00150012L7 | 0.01206 | EQUITY | USD |
| XENCOR | XNCR | 0.13 | ≈$13.0M | 535,361 | 98401F105 | 0.01054 | EQUITY | USD |
| GRIFOLS ADR REPRESENTING ONE NON-V | GRFS | 0.12 | ≈$12.8M | 1,683,241 | 398438408 | 0.03313 | EQUITY | USD |
Market value is estimated from each holding's weight and the fund's net assets. Weight and shares are as reported by the fund.
Sector breakdown
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Sept. 10, 2026 | Trimmed | AARD — AARDVARK THERAPEUTICS | Units/share: 0.001879 → 0.00187 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ABCL — ABCELLERA BIOLOGICS | Units/share: 0.03545 → 0.03528 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ABSI — ABSCI CORP | Units/share: 0.02231 → 0.0222 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ABUS — ARBUTUS BIOPHARMA CORP | Units/share: 0.02376 → 0.02364 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ABVX — ABIVAX AMERICAN DEPOSITARY SHARES | Units/share: 0.009777 → 0.009729 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ACAD — ACADIA PHARMACEUTICALS | Units/share: 0.0256 → 0.02547 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ACIU — AC IMMUNE SA AG | Units/share: 0.009128 → 0.009083 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ACRS — ACLARIS THERAPEUTICS | Units/share: 0.01677 → 0.01669 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ADCT — ADC THERAPEUTICS SA | Units/share: 0.01411 → 0.01404 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ADMA — ADMA BIOLOGICS | Units/share: 0.03416 → 0.03399 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ADPT — ADAPTIVE BIOTECHNOLOGIES | Units/share: 0.02333 → 0.02321 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ADRO — CHINOOK THERAPEUTICS INC | Units/share: 0.006368 → 0.006318 (-0.8%) |
| Sept. 10, 2026 | Trimmed | AGIO — AGIOS PHARMACEUTICALS | Units/share: 0.008414 → 0.008372 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AKE — AKERO THERAPEUTICS CVR | Units/share: 0.01024 → 0.01016 (-0.8%) |
| Sept. 10, 2026 | Trimmed | ALKS — ALKERMES | Units/share: 0.02466 → 0.02454 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ALLO — ALLOGENE THERAPEUTICS | Units/share: 0.03912 → 0.03893 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ALMS — ALUMIS | Units/share: 0.01272 → 0.01265 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ALNY — ALNYLAM PHARMACEUTICALS | Units/share: 0.0201 → 0.02 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ALT — ALTIMMUNE INC | Units/share: 0.02799 → 0.02785 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ALVO — ALVOTECH SA | Units/share: 0.02104 → 0.02093 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AMGN — AMGEN INC | Units/share: 0.04191 → 0.04171 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AMLX — AMYLYX PHARMACEUTICALS | Units/share: 0.01604 → 0.01596 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ANAB — ANAPTYSBIO | Units/share: 0.004118 → 0.004097 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ANNX — ANNEXON | Units/share: 0.0245 → 0.02438 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ANRO — ALTO NEUROSCIENCE INC | Units/share: 0.005332 → 0.005306 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ARCT — ARCTURUS THERAPEUTICS HOLDINGS INC | Units/share: 0.00401 → 0.00399 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ARGX — ARGENX SE ADR | Units/share: 0.007856 → 0.007817 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ARQT — ARCUTIS BIOTHERAPEUTICS | Units/share: 0.01668 → 0.01659 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ARVN — ARVINAS | Units/share: 0.008317 → 0.008276 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ARWR — ARROWHEAD PHARMACEUTICALS | Units/share: 0.02001 → 0.01991 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ASND — ASCENDIS PHARMA | Units/share: 0.009348 → 0.009302 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AUPH — AURINIA PHARMACEUTICALS | Units/share: 0.01717 → 0.01708 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AURA — AURA BIOSCIENCES | Units/share: 0.009907 → 0.009858 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AUTL — AUTOLUS THERAPEUTICS ADR PLC | Units/share: 0.03013 → 0.02998 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AVBP — ARRIVENT BIOPHARMA | Units/share: 0.004918 → 0.004894 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AVIR — ATEA PHARMACEUTICALS | Units/share: 0.009635 → 0.009587 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AVXL — ANAVEX LIFE SCIENCES CORP | Units/share: 0.01332 → 0.01326 (-0.5%) |
| Sept. 10, 2026 | Trimmed | AXSM — AXSOME THERAPEUTICS | Units/share: 0.006503 → 0.006471 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BBIO — BRIDGEBIO PHARMA | Units/share: 0.02556 → 0.02544 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BBOT — BRIDGEBIO ONCOLOGY THERAPEUTICS IN | Units/share: 0.006692 → 0.006658 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BCAX — BICARA THERAPEUTICS INC | Units/share: 0.005656 → 0.005628 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BCRX — BIOCRYST PHARMACEUTICALS | Units/share: 0.03266 → 0.0325 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BCYC — BICYCLE THERAPEUTICS ADR PLC | Units/share: 0.005567 → 0.005539 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BDTX — BLACK DIAMOND THERAPEUTICS INC | Units/share: 0.007319 → 0.007283 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BEAM — BEAM THERAPEUTICS | Units/share: 0.01416 → 0.01409 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BHVN — BIOHAVEN | Units/share: 0.01894 → 0.01885 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BIIB — BIOGEN | Units/share: 0.02213 → 0.02202 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BIOA — BIOAGE LABS | Units/share: 0.00471 → 0.004687 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BMRN — BIOMARIN PHARMACEUTICAL | Units/share: 0.02877 → 0.02863 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BNTX — BIONTECH SE ADR | Units/share: 0.01381 → 0.01374 (-0.5%) |
| Sept. 10, 2026 | Trimmed | BRKR — BRUKER | Units/share: 0.01682 → 0.01674 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CABA — CABALETTA BIO | Units/share: 0.02186 → 0.02175 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CADL — CANDEL THERAPEUTICS INC | Units/share: 0.008822 → 0.008778 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CAI — CARIS LIFE SCIENCES | Units/share: 0.0185 → 0.01841 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CATX — PERSPECTIVE THERAPEUTICS | Units/share: 0.01342 → 0.01335 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CCCC — C4 THERAPEUTICS | Units/share: 0.01673 → 0.01664 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CDNA — CAREDX | Units/share: 0.007046 → 0.007011 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CDXS — CODEXIS | Units/share: 0.01516 → 0.01508 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CGEM — CULLINAN THERAPEUTICS | Units/share: 0.006827 → 0.006793 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CGON — CG ONCOLOGY | Units/share: 0.008681 → 0.008638 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CLLS — CELLECTIS ADR REPRESENTING SA | Units/share: 0.004704 → 0.004681 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CMPS — COMPASS PATHWAYS ADR PLC | Units/share: 0.01644 → 0.01636 (-0.5%) |
| Sept. 10, 2026 | Trimmed | COGT — COGENT BIOSCIENCES | Units/share: 0.02227 → 0.02216 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CRBU — CARIBOU BIOSCIENCES | Units/share: 0.01326 → 0.01319 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CRGX — CARGO THERAPEUTICS INC | Units/share: 0.003931 → 0.0039 (-0.8%) |
| Sept. 10, 2026 | Trimmed | CRL — CHARLES RIVER LABORATORIES INTERNA | Units/share: 0.007196 → 0.00716 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CRSP — CRISPR THERAPEUTICS AG | Units/share: 0.01356 → 0.0135 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CRVS — CORVUS PHARMACEUTICALS | Units/share: 0.009532 → 0.009485 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CSTL — CASTLE BIOSCIENCES | Units/share: 0.004473 → 0.004451 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CTKB — CYTEK BIOSCIENCES | Units/share: 0.01803 → 0.01794 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CTMX — CYTOMX THERAPEUTICS | Units/share: 0.02544 → 0.02531 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CTNM — CONTINEUM THERAPEUTICS CLASS A | Units/share: 0.00445 → 0.004428 (-0.5%) |
| Sept. 10, 2026 | Trimmed | CYTK — CYTOKINETICS | Units/share: 0.02018 → 0.02008 (-0.5%) |
| Sept. 10, 2026 | Trimmed | DFTX — DEFINIUM THERAPEUTICS INC | Units/share: 0.01928 → 0.01919 (-0.5%) |
| Sept. 10, 2026 | Trimmed | DNA — GINKGO BIOWORKS HOLDINGS CLASS A | Units/share: 0.007512 → 0.007475 (-0.5%) |
| Sept. 10, 2026 | Trimmed | DNLI — DENALI THERAPEUTICS | Units/share: 0.02247 → 0.02235 (-0.5%) |
| Sept. 10, 2026 | Trimmed | DSGN — DESIGN THERAPEUTICS | Units/share: 0.005747 → 0.005718 (-0.5%) |
| Sept. 10, 2026 | Trimmed | DYN — DYNE THERAPEUTICS | Units/share: 0.0226 → 0.02249 (-0.5%) |
| Sept. 10, 2026 | Trimmed | EBS — EMERGENT BIOSOLUTIONS | Units/share: 0.007244 → 0.007208 (-0.5%) |
| Sept. 10, 2026 | Trimmed | EDIT — EDITAS MEDICINE | Units/share: 0.02178 → 0.02168 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ELVN — ENLIVEN THERAPEUTICS | Units/share: 0.008377 → 0.008335 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ENTA — ENANTA PHARMACEUTICALS INC | Units/share: 0.004106 → 0.004086 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ERAS — ERASCA | Units/share: 0.03721 → 0.03703 (-0.5%) |
| Sept. 10, 2026 | Trimmed | EWTX — EDGEWISE THERAPEUTICS | Units/share: 0.01185 → 0.01179 (-0.5%) |
| Sept. 10, 2026 | Trimmed | EXEL — EXELIXIS INC | Units/share: 0.03683 → 0.03664 (-0.5%) |
| Sept. 10, 2026 | Trimmed | FDMT — 4D MOLECULAR THERAPEUTICS INC | Units/share: 0.007084 → 0.007049 (-0.5%) |
| Sept. 10, 2026 | Trimmed | FHTX — FOGHORN THERAPEUTICS | Units/share: 0.004677 → 0.004654 (-0.5%) |
| Sept. 10, 2026 | Trimmed | FLGT — FULGENT GENETICS | Units/share: 0.002719 → 0.002705 (-0.5%) |
| Sept. 10, 2026 | Trimmed | FTRE — FORTREA HOLDINGS INC | Units/share: 0.01423 → 0.01416 (-0.5%) |
| Sept. 10, 2026 | Trimmed | FULC — FULCRUM THERAPEUTICS | Units/share: 0.011 → 0.01094 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GERN — GERON | Units/share: 0.09463 → 0.09417 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GHRS — GH RESEARCH PLC | Units/share: 0.007446 → 0.007409 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GILD — GILEAD SCIENCES | Units/share: 0.105 → 0.1045 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GLUE — MONTE ROSA THERAPEUTICS | Units/share: 0.008829 → 0.008785 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GMAB — GENMAB SPONSORED ADR | Units/share: 0.07897 → 0.07858 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GOSS — GOSSAMER BIO | Units/share: 0.06699 → 0.06666 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GPCR — STRUCTURE THERAPEUTICS ADR | Units/share: 0.008826 → 0.008783 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GRAL — GRAIL INC | Units/share: 0.005985 → 0.005955 (-0.5%) |
| Sept. 10, 2026 | Trimmed | GRFS — GRIFOLS ADR REPRESENTING ONE NON-V | Units/share: 0.0333 → 0.03313 (-0.5%) |
| Sept. 10, 2026 | Trimmed | HALO — HALOZYME THERAPEUTICS | Units/share: 0.01775 → 0.01766 (-0.5%) |
| Sept. 10, 2026 | Trimmed | HUMA — HUMACYTE INC | Units/share: 0.03661 → 0.03643 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IBRX — IMMUNITYBIO | Units/share: 0.0568 → 0.05652 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IDYA — IDEAYA BIOSCIENCES | Units/share: 0.01255 → 0.01248 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ILMN — ILLUMINA INC | Units/share: 0.02282 → 0.0227 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IMCR — IMMUNOCORE HOLDINGS ADR PLC | Units/share: 0.006423 → 0.006391 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IMMP — IMMUTEP ADS REPRESENTING LTD | Units/share: 0.01547 → 0.01539 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IMRX — IMMUNEERING CLASS A | Units/share: 0.008573 → 0.008531 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IMVT — IMMUNOVANT | Units/share: 0.01223 → 0.01217 (-0.5%) |
| Sept. 10, 2026 | Trimmed | INBX — INHIBRX BIOSCIENCES INC | Units/share: 0.001637 → 0.001629 (-0.5%) |
| Sept. 10, 2026 | Trimmed | INCY — INCYTE CORP | Units/share: 0.02993 → 0.02978 (-0.5%) |
| Sept. 10, 2026 | Trimmed | INSM — INSMED | Units/share: 0.03246 → 0.0323 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IONS — IONIS PHARMACEUTICALS | Units/share: 0.02451 → 0.02439 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IOVA — IOVANCE BIOTHERAPEUTICS INC | Units/share: 0.05859 → 0.0583 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IRON — DISC MEDICINE | Units/share: 0.004191 → 0.00417 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IRWD — IRONWOOD PHARMA CLASS A | Units/share: 0.02403 → 0.02391 (-0.5%) |
| Sept. 10, 2026 | Trimmed | IXCU6 — E-MINI HEALTH CARE SECTOR SEP 26 | Units/share: 0.000001548 → 0.000001535 (-0.8%) |
| Sept. 10, 2026 | Trimmed | JANX — JANUX THERAPEUTICS | Units/share: 0.008623 → 0.008581 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KOD — KODIAK SCIENCES | Units/share: 0.008773 → 0.00873 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KROS — KEROS THERAPEUTICS | Units/share: 0.002709 → 0.002696 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KRYS — KRYSTAL BIOTECH | Units/share: 0.00389 → 0.003871 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KURA — KURA ONCOLOGY | Units/share: 0.01295 → 0.01289 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KYMR — KYMERA THERAPEUTICS | Units/share: 0.01076 → 0.01071 (-0.5%) |
| Sept. 10, 2026 | Trimmed | KYTX — KYVERNA THERAPEUTICS | Units/share: 0.005613 → 0.005585 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LAB — STANDARD BIOTOOLS | Units/share: 0.05585 → 0.05558 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LCTX — LINEAGE CELL THERAPEUTICS INC | Units/share: 0.02788 → 0.02774 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LEGN — LEGEND BIOTECH ADR REP | Units/share: 0.0224 → 0.02229 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LENZ — LENZ THERAPEUTICS | Units/share: 0.00407 → 0.00405 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LKFT — LAKEFRONT BIOTHERAPEUTICS ADR NV | Units/share: 0.006235 → 0.006204 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LRMR — LARIMAR THERAPEUTICS | Units/share: 0.007813 → 0.007775 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LXEO — LEXEO THERAPEUTICS | Units/share: 0.009174 → 0.009128 (-0.5%) |
| Sept. 10, 2026 | Trimmed | LYEL — LYELL IMMUNOPHARMA | Units/share: 0.001141 → 0.001135 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MAZE — MAZE THERAPEUTICS | Units/share: 0.005188 → 0.005163 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MBX — MBX BIOSCIENCES | Units/share: 0.004454 → 0.004432 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MDGL — MADRIGAL PHARMACEUTICALS | Units/share: 0.00328 → 0.003264 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MEDP — MEDPACE HOLDINGS | Units/share: 0.003479 → 0.003461 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MENS — JYONG BIOTECH LTD | Units/share: 0.004328 → 0.004306 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MESO — MESOBLAST ADR REPRESENTING | Units/share: 0.01055 → 0.0105 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MGTX — MEIRAGTX HOLDINGS PLC | Units/share: 0.01058 → 0.01053 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MIRM — MIRUM PHARMACEUTICALS | Units/share: 0.00751 → 0.007473 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MLYS — MINERALYS THERAPEUTICS | Units/share: 0.00917 → 0.009125 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MNKD — MANNKIND | Units/share: 0.04481 → 0.04458 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MRNA — MODERNA | Units/share: 0.05493 → 0.05466 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MRVI — MARAVAI LIFESCIENCES HOLDINGS INC | Units/share: 0.01591 → 0.01583 (-0.5%) |
| Sept. 10, 2026 | Trimmed | MYGN — MYRIAD GENETICS | Units/share: 0.01316 → 0.01309 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NAMS — NEWAMSTERDAM PHARMA | Units/share: 0.01212 → 0.01206 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NBIX — NEUROCRINE BIOSCIENCES | Units/share: 0.01494 → 0.01486 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NBP — NOVABRIDGE BIOSCIENCES ADR | Units/share: 0.01247 → 0.01241 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NGNE — NEUROGENE | Units/share: 0.002374 → 0.002362 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NMRA — NEUMORA THERAPEUTICS INC | Units/share: 0.01146 → 0.01141 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NRIX — NURIX THERAPEUTICS | Units/share: 0.01483 → 0.01475 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NTLA — INTELLIA THERAPEUTICS | Units/share: 0.01998 → 0.01988 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NTRA — NATERA | Units/share: 0.02065 → 0.02054 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NUVB — NUVATION BIO CLASS A | Units/share: 0.03741 → 0.03723 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NVAX — NOVAVAX | Units/share: 0.02363 → 0.02351 (-0.5%) |
| Sept. 10, 2026 | Trimmed | NVCR — NOVOCURE | Units/share: 0.01575 → 0.01567 (-0.5%) |
| Sept. 10, 2026 | Trimmed | OABI — OMNIAB INC | Units/share: 0.01788 → 0.0178 (-0.5%) |
| Sept. 10, 2026 | Trimmed | OLMA — OLEMA PHARMACEUTICALS | Units/share: 0.01071 → 0.01066 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ONC — BEONE MEDICINES AG | Units/share: 0.01204 → 0.01198 (-0.5%) |
| Sept. 10, 2026 | Trimmed | OPK — OPKO HEALTH | Units/share: 0.05738 → 0.0571 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ORIC — ORIC PHARMACEUTICALS | Units/share: 0.009263 → 0.009217 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ORKA — ORUKA THERAPEUTICS INC | Units/share: 0.007665 → 0.007627 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PACB — PACIFIC BIOSCIENCES OF CALIFORNIA | Units/share: 0.04337 → 0.04316 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PCVX — VAXCYTE | Units/share: 0.02135 → 0.02125 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PEPG — PEPGEN | Units/share: 0.00945 → 0.009403 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PGEN — PRECIGEN | Units/share: 0.02385 → 0.02374 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PHAT — PHATHOM PHARMACEUTICALS | Units/share: 0.00869 → 0.008647 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PHVS — PHARVARIS N V | Units/share: 0.004432 → 0.00441 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PRAX — PRAXIS PRECISION MEDICINES | Units/share: 0.003948 → 0.003929 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PRME — PRIME MEDICINE | Units/share: 0.01413 → 0.01406 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PRTA — PROTHENA PLC | Units/share: 0.00695 → 0.006915 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PSNL — PERSONALIS | Units/share: 0.009344 → 0.009298 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PTCT — PTC THERAPEUTICS | Units/share: 0.01213 → 0.01207 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PTGX — PROTAGONIST THERAPEUTICS | Units/share: 0.009228 → 0.009183 (-0.5%) |
| Sept. 10, 2026 | Trimmed | PYXS — PYXIS ONCOLOGY INC | Units/share: 0.01016 → 0.01011 (-0.5%) |
| Sept. 10, 2026 | Trimmed | QSI — QUANTUM SI INC CLASS A | Units/share: 0.02526 → 0.02513 (-0.5%) |
| Sept. 10, 2026 | Trimmed | QTRX — QUANTERIX | Units/share: 0.005913 → 0.005884 (-0.5%) |
| Sept. 10, 2026 | Trimmed | QURE — UNIQURE | Units/share: 0.009735 → 0.009687 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RAPP — RAPPORT THERAPEUTICS | Units/share: 0.004279 → 0.004257 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RARE — ULTRAGENYX PHARMACEUTICAL | Units/share: 0.01361 → 0.01354 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RCKT — ROCKET PHARMACEUTICALS | Units/share: 0.01596 → 0.01588 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RCUS — ARCUS BIOSCIENCES | Units/share: 0.01266 → 0.01259 (-0.5%) |
| Sept. 10, 2026 | Trimmed | REGN — REGENERON PHARMACEUTICALS | Units/share: 0.01526 → 0.01518 (-0.5%) |
| Sept. 10, 2026 | Trimmed | REPL — REPLIMUNE GROUP | Units/share: 0.0132 → 0.01313 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RGEN — REPLIGEN | Units/share: 0.008058 → 0.008018 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RGNX — REGENXBIO | Units/share: 0.008811 → 0.008767 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RIGL — RIGEL PHARMACEUTICALS | Units/share: 0.002704 → 0.00269 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RLAY — RELAY THERAPEUTICS | Units/share: 0.02475 → 0.02463 (-0.5%) |
| Sept. 10, 2026 | Trimmed | ROIV — ROIVANT SCIENCES LTD | Units/share: 0.07806 → 0.07768 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RTYU6 — RUSSELL 2000 EMINI CME SEP 26 | Units/share: 0.0000007341 → 0.0000007283 (-0.8%) |
| Sept. 10, 2026 | Trimmed | RVMD — REVOLUTION MEDICINES | Units/share: 0.02879 → 0.02864 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RXRX — RECURSION PHARMACEUTICALS CLASS A | Units/share: 0.07099 → 0.07064 (-0.5%) |
| Sept. 10, 2026 | Trimmed | RYTM — RHYTHM PHARMACEUTICALS | Units/share: 0.01004 → 0.009993 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SANA — SANA BIOTECHNOLOGY | Units/share: 0.02747 → 0.02733 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SEPN — SEPTERNA | Units/share: 0.004126 → 0.004106 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SGAFT — CASH COLLATERAL USD SGAFT | Units/share: 0.02427 → 0.02402 (-1.0%) |
| Sept. 10, 2026 | Trimmed | SGMT — SAGIMET BIOSCIENCES SERIES A | Units/share: 0.008912 → 0.008868 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SION — SIONNA THERAPEUTICS | Units/share: 0.003957 → 0.003937 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SLDB — SOLID BIOSCIENCES INC | Units/share: 0.01183 → 0.01177 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SLN — SILENCE THERAPEUTICS ADR REPRESENT | Units/share: 0.005252 → 0.005227 (-0.5%) |
| Sept. 10, 2026 | Trimmed | SMMT — SUMMIT THERAPEUTICS | Units/share: 0.02033 → 0.02023 (-0.5%) |
Showing latest 200 of 4984 changes
Dividends 56 payments
| Ex-date | Amount / share |
|---|---|
| Sept. 15, 2026 | $0.0110 |
| June 15, 2026 | $0.0240 |
| March 17, 2026 | $0.1220 |
| Dec. 16, 2025 | $0.1830 |
| Sept. 16, 2025 | $0.0830 |
| March 18, 2025 | $0.1210 |
| Dec. 17, 2024 | $0.0620 |
| Sept. 25, 2024 | $0.2000 |
| March 21, 2024 | $0.1260 |
| Dec. 20, 2023 | $0.1240 |
| Sept. 26, 2023 | $0.1530 |
| June 7, 2023 | $0.0060 |
| March 23, 2023 | $0.0650 |
| Dec. 13, 2022 | $0.1010 |
| Sept. 26, 2022 | $0.1590 |
| June 9, 2022 | $0.0310 |
| March 24, 2022 | $0.1180 |
| Dec. 13, 2021 | $0.0410 |
| Sept. 24, 2021 | $0.1240 |
| June 10, 2021 | $0.0230 |
| March 25, 2021 | $0.1310 |
| Dec. 14, 2020 | $0.0650 |
| Sept. 23, 2020 | $0.0630 |
| June 15, 2020 | $0.1270 |
| March 25, 2020 | $0.0550 |
| Dec. 30, 2019 | $0.0630 |
| Dec. 16, 2019 | $0.0580 |
| Sept. 24, 2019 | $0.0710 |
| June 17, 2019 | $0.0800 |
| March 20, 2019 | $0.1270 |
| Sept. 26, 2018 | $0.0320 |
| June 26, 2018 | $0.1560 |
| Dec. 21, 2017 | $0.1250 |
| Sept. 26, 2017 | $0.0397 |
| June 27, 2017 | $0.0590 |
| March 24, 2017 | $0.0997 |
| Dec. 22, 2016 | $0.0307 |
| Sept. 26, 2016 | $0.0287 |
| June 21, 2016 | $0.0540 |
| March 23, 2016 | $0.0510 |
| Dec. 24, 2015 | $0.0107 |
| Sept. 25, 2015 | $0.0007 |
| June 24, 2015 | $0.0193 |
| Sept. 24, 2014 | $0.0180 |
| June 25, 2014 | $0.1310 |
| June 27, 2013 | $0.0240 |
| Dec. 19, 2012 | $0.0343 |
| Sept. 24, 2012 | $0.1133 |
| June 22, 2012 | $0.0620 |
| March 23, 2012 | $0.0090 |
| Dec. 22, 2011 | $0.0047 |
| Sept. 24, 2010 | $0.1700 |
| June 24, 2008 | $0.0590 |
| June 29, 2007 | $0.0293 |
| Dec. 21, 2006 | $0.0003 |
| Dec. 23, 2005 | $0.0003 |
Institutional owners (13F) 1,028 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | $1,307,581,175 | 16.63% | 6,875,131 | Shares | June 30, 2026 |
| CITIGROUP INC | $905,439,324 | 11.52% | 4,760,709 | Shares | June 30, 2026 |
| MORGAN STANLEY | $631,616,841 | 8.03% | 3,320,977 | Shares | June 30, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | $421,829,818 | 5.37% | 2,217,939 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $302,042,070 | 3.84% | 1,588,107 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $223,697,116 | 2.85% | 1,176,177 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $213,518,446 | 2.72% | 1,122,659 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $199,812,347 | 2.54% | 1,050,594 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $195,827,718 | 2.49% | 1,029,643 | Shares | June 30, 2026 |
| COMMERCE BANK | $172,942,620 | 2.20% | 909,315 | Shares | June 30, 2026 |
| UBS Group AG | $164,014,721 | 2.09% | 862,373 | Shares | June 30, 2026 |
| PEAK6 LLC | $157,876,719 | 2.01% | 830,100 | Call option | June 30, 2026 |
| LPL Financial LLC | $150,135,091 | 1.91% | 789,395 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $142,576,000 | 1.81% | 749,649 | Shares | June 30, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $138,077,940 | 1.76% | 726,000 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $128,825,749 | 1.64% | 677,353 | Shares | June 30, 2026 |
| WestEnd Advisors, LLC | $124,744,693 | 1.59% | 655,852 | Shares | June 30, 2026 |
| JPMORGAN CHASE & CO | $119,603,927 | 1.52% | 630,190 | Shares | June 30, 2026 |
| BARCLAYS PLC | $100,086,537 | 1.27% | 526,245 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79,613,534 | 1.01% | 418,600 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68,886,818 | 0.88% | 362,200 | Call option | June 30, 2026 |
| PNC Financial Services Group, Inc. | $59,815,796 | 0.76% | 314,505 | Shares | June 30, 2026 |
| Jefferies Financial Group Inc. | $57,495,733 | 0.73% | 302,306 | Shares | June 30, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | $44,563,427 | 0.57% | 234,310 | Shares | June 30, 2026 |
| STIFEL FINANCIAL CORP | $33,234,928 | 0.42% | 174,738 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $31,096,065 | 0.40% | 163,500 | Call option | June 30, 2026 |
| Rockefeller Capital Management L.P. | $27,835,713 | 0.35% | 146,356 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $26,214,727 | 0.33% | 137,834 | Shares | June 30, 2026 |
| AMERIPRISE FINANCIAL INC | $25,071,090 | 0.32% | 131,138 | Shares | June 30, 2026 |
| Focus Partners Wealth | $24,013,121 | 0.31% | 126,258 | Shares | June 30, 2026 |
| ALBION FINANCIAL GROUP /UT | $22,753,461 | 0.29% | 119,635 | Shares | June 30, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | $22,083,912 | 0.28% | 116,115 | Shares | June 30, 2026 |
| Cetera Investment Advisers | $22,024,704 | 0.28% | 115,804 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $20,730,710 | 0.26% | 109,000 | Put option | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $19,423,202 | 0.25% | 102,066 | Shares | June 30, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $19,368,569 | 0.25% | 101,838 | Shares | June 30, 2026 |
| Itau Unibanco Holding S.A. | $18,805,226 | 0.24% | 98,876 | Shares | June 30, 2026 |
| INVESTMENT HOUSE LLC | $18,394,226 | 0.23% | 96,715 | Shares | June 30, 2026 |
| ExodusPoint Capital Management, LP | $18,265,467 | 0.23% | 96,038 | Shares | June 30, 2026 |
| Erste Asset Management GmbH | $17,342,761 | 0.22% | 102,330 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $16,869,853 | 0.21% | 88,700 | Put option | June 30, 2026 |
| MAI Capital Management | $16,489,588 | 0.21% | 86,701 | Shares | June 30, 2026 |
| MML INVESTORS SERVICES, LLC | $16,284,678 | 0.21% | 85,623 | Shares | June 30, 2026 |
| ASSETMARK, INC | $16,221,132 | 0.21% | 85,289 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $15,614,599 | 0.20% | 82,100 | Call option | June 30, 2026 |
| Creative Planning | $13,860,610 | 0.18% | 72,878 | Shares | June 30, 2026 |
| FACTORY MUTUAL INSURANCE CO | $13,503,490 | 0.17% | 71,000 | Shares | June 30, 2026 |
| D. E. Shaw & Co., Inc. | $13,117,594 | 0.17% | 68,971 | Shares | June 30, 2026 |
| Bronte Capital Management Pty Ltd. | $12,515,833 | 0.16% | 65,807 | Shares | June 30, 2026 |
| CUMBERLAND ADVISORS INC | $12,175,583 | 0.15% | 64,018 | Shares | June 30, 2026 |
| NTV Asset Management LLC | $12,169,323 | 0.15% | 63,985 | Shares | June 30, 2026 |
| Cerity Partners LLC | $12,113,838 | 0.15% | 63,694 | Shares | June 30, 2026 |
| Beacon Pointe Advisors, LLC | $12,038,493 | 0.15% | 63,297 | Shares | June 30, 2026 |
| Tradition Wealth Management, LLC | $11,826,840 | 0.15% | 62,184 | Shares | June 30, 2026 |
| FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC | $11,607,345 | 0.15% | 61,030 | Shares | June 30, 2026 |
| Horizon Wealth Management, LLC | $11,465,582 | 0.15% | 60,285 | Shares | June 30, 2026 |
| Apella Capital, LLC | $11,404,083 | 0.15% | 57,530 | Shares | June 30, 2026 |
| Corient Private Wealth LP | $10,796,186 | 0.14% | 56,763 | Shares | June 30, 2026 |
| Pictet Asset Management Holding SA | $10,428,961 | 0.13% | 54,950 | Shares | June 30, 2026 |
| Parker Investment Management, LLC | $10,423,041 | 0.13% | 54,803 | Shares | June 30, 2026 |
| BROWN ADVISORY INC | $10,421,103 | 0.13% | 54,793 | Shares | June 30, 2026 |
| CAPITAL FUND MANAGEMENT S.A. | $10,107,647 | 0.13% | 53,145 | Shares | June 30, 2026 |
| Reyes Financial Architecture, Inc. | $10,058,198 | 0.13% | 52,885 | Shares | June 30, 2026 |
| Waverly Advisors, LLC | $9,987,833 | 0.13% | 52,515 | Shares | June 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | $9,884,935 | 0.13% | 51,974 | Shares | June 30, 2026 |
| Sanctuary Advisors, LLC | $9,795,378 | 0.12% | 51,503 | Shares | June 30, 2026 |
| Humankind Investments LLC | $9,509,500 | 0.12% | 50,000 | Shares | June 30, 2026 |
| IFP Advisors, Inc | $9,507,218 | 0.12% | 49,988 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $9,190,076 | 0.12% | 48,321 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $8,991,803 | 0.11% | 47,278 | Shares | June 30, 2026 |
| Kestra Advisory Services, LLC | $8,975,993 | 0.11% | 47,195 | Shares | June 30, 2026 |
| Henshaw Capital LLC | $8,938,930 | 0.11% | 47,000 | Shares | June 30, 2026 |
| L & S Advisors Inc | $8,757,108 | 0.11% | 46,044 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $8,749,554 | 0.11% | 46,004 | Shares | June 30, 2026 |
| DAVENPORT & Co LLC | $8,615,552 | 0.11% | 45,300 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $8,288,262 | 0.11% | 58,200 | Put option | Sept. 30, 2025 |
| FORBES J M & CO LLP | $8,248,730 | 0.10% | 43,371 | Shares | June 30, 2026 |
| DAFNA Capital Management LLC | $8,101,143 | 0.10% | 42,595 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $8,037,702 | 0.10% | 42,261 | Shares | June 30, 2026 |
| Concurrent Investment Advisors, LLC | $7,968,858 | 0.10% | 41,899 | Shares | June 30, 2026 |
| SP Asset Management LLC | $7,838,297 | 0.10% | 41,213 | Shares | June 30, 2026 |
| First Interstate Bank | $7,707,640 | 0.10% | 40,526 | Shares | June 30, 2026 |
| Summit Financial, LLC | $7,552,142 | 0.10% | 39,708 | Shares | June 30, 2026 |
| EQUITABLE TRUST CO | $7,540,083 | 0.10% | 39,645 | Shares | June 30, 2026 |
| MMBG INVESTMENT ADVISORS CO. | $7,158,181 | 0.09% | 37,637 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $6,741,296 | 0.09% | 35,445 | Shares | June 30, 2026 |
| BEARING POINT CAPITAL, LLC | $6,714,468 | 0.09% | 35,304 | Shares | June 30, 2026 |
| Michelson Medical Research Foundation, Inc. | $6,674,718 | 0.08% | 35,095 | Shares | June 30, 2026 |
| Caption Management, LLC | $6,637,631 | 0.08% | 34,900 | Put option | June 30, 2026 |
| J. Goldman & Co LP | $6,637,631 | 0.08% | 34,900 | Put option | June 30, 2026 |
| Addison Capital Co | $6,542,048 | 0.08% | 34,397 | Shares | June 30, 2026 |
| Williams Jones Wealth Management, LLC. | $6,450,674 | 0.08% | 33,917 | Shares | June 30, 2026 |
| JONES FINANCIAL COMPANIES LLLP | $6,351,704 | 0.08% | 33,901 | Shares | June 30, 2026 |
| WOLVERINE TRADING, LLC | $6,166,353 | 0.08% | 43,300 | Call option | Sept. 30, 2025 |
| Allspring Global Investments Holdings, LLC | $6,147,720 | 0.08% | 32,336 | Shares | June 30, 2026 |
| Equitable Holdings, Inc. | $5,996,315 | 0.08% | 31,528 | Shares | June 30, 2026 |
| Colonial Trust Advisors | $5,970,421 | 0.08% | 31,392 | Shares | June 30, 2026 |
| McCollum Christoferson Group LLC | $5,881,436 | 0.07% | 30,924 | Shares | June 30, 2026 |
| Aristides Capital LLC | $5,782,917 | 0.07% | 30,406 | Shares | June 30, 2026 |
| Y-Intercept (Hong Kong) Ltd | $5,758,953 | 0.07% | 30,280 | Shares | June 30, 2026 |